Compare
Target Group Inc. vs Functional Brands Inc. vs TFA Therapeutics, Inc. vs Bon Natural Life Ltd
| Latest fiscal year | Target Group Inc. CBDY | Functional Brands Inc. MEHA | TFA Therapeutics, Inc. RAJAF | Bon Natural Life Ltd BON |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $3.88M | $6.61M | $1.25M | $18.67M |
| Revenue growth (YoY) | -41.1% | +0.7% | -0.6% | -21.7% |
| Gross margin | 53.3% | 52.7% | 61.1% | 20.8% |
| Operating margin | n/a | -21.2% | -11.3% | -8.7% |
| Net margin | -35.0% | 11.5% | -12.4% | -10.7% |
| Net income | -$1.36M | $758.5K | -$154.8K | -$1.99M |
| EPS (Diluted) | $0.00 | $0.01 | $0.00 | -$0.72 |
| Operating cash flow | -$842.4K | -$1.27M | -$35.8K | $141.1K |
| Free cash flow | n/a | -$1.28M | n/a | $134.3K |
| Cash & equivalents | n/a | $2.73M | $3.2K | n/a |
| Total assets | $6.18M | $9.11M | $4.66M | $85.19M |
| Total liabilities | $14.24M | $7.57M | $5.19M | $27.19M |
| Shareholders' equity | -$8.06M | $1.54M | -$534.6K | $58.00M |
| Return on year-end equity | n/a | 49.2% | n/a | -3.4% |
| Shares outstanding | 617.03M | 18.70M | 111.12M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Target Group Inc. | Functional Brands Inc. | TFA Therapeutics, Inc. | Bon Natural Life Ltd |
|---|---|---|---|---|
| Latest | $3.88M Ended 2025-12-31 | $6.61M Ended 2025-12-31 | $1.25M Ended 2025-12-31 | $18.67M Ended 2025-09-30 |
| 1 year earlier | $6.59M Ended 2024-12-31 | $6.57M Ended 2024-12-31 | $1.25M Ended 2024-12-31 | $23.84M Ended 2024-09-30 |
| 2 years earlier | $3.72M Ended 2023-12-31 | n/a | $882.5K Ended 2023-12-31 | $29.52M Ended 2023-09-30 |
| 3 years earlier | $0 Ended 2022-12-31 | n/a | $53.3K Ended 2022-12-31 | $29.91M Ended 2022-09-30 |
| 4 years earlier | $0 Ended 2021-12-31 | n/a | $879.3K Ended 2021-12-31 | $25.49M Ended 2021-09-30 |